These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 6172157

  • 1. Interaction of tryptophan-modified analogues of cholecystokinin-octapeptide with cholecystokinin receptors on pancreatic acini.
    Adachi H, Rajh HM, Tesser GI, de Pont JJ, Jensen RT, Gardner JD.
    Biochim Biophys Acta; 1981 Dec 18; 678(3):358-63. PubMed ID: 6172157
    [Abstract] [Full Text] [Related]

  • 2. The importance of the amino acid in position 32 of cholecystokinin in determining its interaction with cholecystokinin receptors on pancreatic acini.
    Pan GZ, Martinez J, Bodanszky M, Jensen RT, Gardner JD.
    Biochim Biophys Acta; 1981 Dec 18; 678(3):352-7. PubMed ID: 6172156
    [Abstract] [Full Text] [Related]

  • 3. N-terminal fragments of CCK-(26-33) as cholecystokinin receptor antagonists in guinea pig pancreatic acini.
    Gardner JD, Knight M, Sutliff VE, Jensen RT.
    Am J Physiol; 1985 Jan 18; 248(1 Pt 1):G98-102. PubMed ID: 2578257
    [Abstract] [Full Text] [Related]

  • 4. Selective modification of the ability of cholecystokinin to cause residual stimulation of pancreatic enzyme secretion.
    Villanueva ML, Martinez J, Bodanszky M, Collins SM, Jensen RT, Gardner JD.
    Am J Physiol; 1982 Sep 18; 243(3):G214-7. PubMed ID: 6180646
    [Abstract] [Full Text] [Related]

  • 5. Derivatives of CCK-(26-32) as cholecystokinin receptor antagonists in guinea pig pancreatic acini.
    Gardner JD, Knight M, Sutliff VE, Tamminga CA, Jensen RT.
    Am J Physiol; 1984 Mar 18; 246(3 Pt 1):G292-5. PubMed ID: 6199984
    [Abstract] [Full Text] [Related]

  • 6. The importance of the amino acid in position 27 of cholecystokinin in determining its biological activity on pancreatic acini.
    Gardner JD, Walker MD, Martinez J, Priestly GP, Natarajan S, Bodanszky M.
    Biochim Biophys Acta; 1980 Jul 03; 630(3):323-9. PubMed ID: 6156709
    [Abstract] [Full Text] [Related]

  • 7. 2-Phenylethyl ester and 2-phenylethyl amide derivative analogues of the C-terminal hepta- and octapeptide of cholecystokinin.
    Fulcrand P, Rodriguez M, Galas MC, Lignon MF, Laur J, Aumelas A, Martinez J.
    Int J Pept Protein Res; 1988 Nov 03; 32(5):384-95. PubMed ID: 2463231
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and biological activity of some partially modified retro-inverso analogues of cholecystokinin.
    Rodriguez M, Galas MC, Lignon MF, Mendre C, Laur J, Aumelas A, Martinez J.
    J Med Chem; 1989 Oct 03; 32(10):2331-9. PubMed ID: 2477546
    [Abstract] [Full Text] [Related]

  • 9. An analogue of substance P with broad receptor antagonist activity.
    Zhang L, Mantey S, Jensen RT, Gardner JD.
    Biochim Biophys Acta; 1988 Oct 28; 972(1):37-44. PubMed ID: 2460143
    [Abstract] [Full Text] [Related]

  • 10. Structure-activity relationship studies on cholecystokinin: analogues with partial agonist activity.
    Galas MC, Lignon MF, Rodriguez M, Mendre C, Fulcrand P, Laur J, Martinez J.
    Am J Physiol; 1988 Feb 28; 254(2 Pt 1):G176-82. PubMed ID: 2450468
    [Abstract] [Full Text] [Related]

  • 11. Cholecystokinin-27-32-amide. A member of a new class of cholecystokinin receptor antagonists.
    Spanarkel M, Martinez J, Briet C, Jensen RT, Gardner JD.
    J Biol Chem; 1983 Jun 10; 258(11):6746-9. PubMed ID: 6304053
    [Abstract] [Full Text] [Related]

  • 12. Structure-function studies of N-acyl derivatives of tryptophan that function as specific cholecystokinin receptor antagonists.
    Jensen RT, Jones SW, Gardner JD.
    Biochim Biophys Acta; 1983 Dec 27; 761(3):269-77. PubMed ID: 6317050
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Proglumide and benzotript: members of a different class of cholecystokinin receptor antagonists.
    Hahne WF, Jensen RT, Lemp GF, Gardner JD.
    Proc Natl Acad Sci U S A; 1981 Oct 27; 78(10):6304-8. PubMed ID: 6171817
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Carbobenzoxy amino acids: structural requirements for cholecystokinin receptor antagonist activity.
    Maton PN, Sutliff VE, Jensen RT, Gardner JD.
    Am J Physiol; 1985 Apr 27; 248(4 Pt 1):G479-84. PubMed ID: 2580448
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.